Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toxicological studies on halopredone acetate.

L Casilli, M Sauro, L M Biraschi

    Arzneimittel-Forschung
    |January 1, 1977
    PubMed
    Summary

    Halopredone acetate, a new topical anti-inflammatory steroid, demonstrated favorable safety in laboratory animals. It showed no gastric ulcer or teratogenic effects and was well-tolerated in skin application studies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Real-world postprogression outcomes after first-line treatment with ribociclib plus aromatase inhibitor versus aromatase inhibitor alone in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in the United States of America.

    ESMO open·2026
    Same author

    Unleashing the power of anti-HER2 therapies in metastatic colorectal cancer: paving the way for a brighter future.

    ESMO gastrointestinal oncology·2026
    Same author

    Cyclin-dependent kinase 4/6 inhibitors beyond progression in hormone receptor-positive, HER2-negative advanced breast cancer: a systematic review and meta-analysis (REIGNITE study).

    ESMO open·2025
    Same author

    Survival outcomes and the role of DNADX ctDNA testing in patients treated with sacituzumab govitecan for metastatic breast cancer.

    ESMO open·2025
    Same author

    Adjuvant capecitabine in patients with triple-negative breast cancer after neoadjuvant chemotherapy.

    ESMO open·2025
    Same author

    Outcomes with trastuzumab deruxtecan by biomarker status, line of treatment and prior receipt of sacituzumab govitecan in a large real-world database of patients with metastatic breast cancer.

    ESMO open·2025

    Area of Science:

    • Pharmacology
    • Toxicology
    • Dermatology

    Background:

    • A novel topical anti-inflammatory steroid, halopredone acetate, was developed for potential therapeutic use.
    • Evaluating the safety profile of new pharmaceutical compounds is crucial before clinical application.

    Purpose of the Study:

    • To conduct a comprehensive toxicological evaluation of halopredone acetate in laboratory animals.
    • To compare the safety of halopredone acetate with existing corticosteroids.

    Main Methods:

    • Acute and subacute toxicity studies were performed in mice and rats.
    • Gastric ulcer induction and teratogenicity assessments were conducted in rats and rabbits.
    • Repeated topical application studies on mouse skin were carried out over four months.

    Main Results:

    • Halopredone acetate exhibited favorable safety compared to hydrocortisone acetate and potent synthetic corticoids.
    • No gastric ulcers were observed in rats following repeated administration.
    • No teratogenic effects were detected in rats and rabbits.
    • Four months of daily topical application on mouse skin was well-tolerated.

    Conclusions:

    • Halopredone acetate presents a favorable safety profile in preclinical toxicological studies.
    • The compound demonstrates potential as a safe topical anti-inflammatory agent.
    • Further clinical investigations are warranted based on these positive safety findings.

    Related Experiment Videos